PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | |vascular disease |
| Sentences | 82 |
| PubMedID- 23323622 | Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. |
| PubMedID- 21516134 | Although several studies have reported that the chemerin/chemr23 axis is strongly associated with cardiovascular disease and aspects of metabolic syndrome11, 26, 27, there was no direct evidence for the role of the chemerin/chemr23 axis in maintaining endothelial function. |
| PubMedID- 26525819 | Thus, primary and secondary prevention of cerebrovascular disease in patients with metabolic syndrome should include haemangiocorrective, antithrombotic, antioxidant and endothelium-protective treatment, as well as therapy of the main components of metabolic syndrome. |
| PubMedID- 20553596 | Given the prognostic significance of the metabolic syndrome in patients with vascular disease, we evaluated the association of vfa, sfa and lfp with metabolic syndrome in a high-risk vascular cohort. |
| PubMedID- 19958158 | Background: metabolic syndrome is associated with cardiovascular disease and oxidative stress. |
| PubMedID- 21122628 | Background: metabolic syndrome is associated with increased cardiovascular disease (cvd) risk, a risk that is significantly increased when accompanied by elevated low-density lipoprotein cholesterol (ldl-c). |
| PubMedID- 24453423 | Importantly also, whereas consistent disparities in the associations of cardiovascular risk factors including crp concentrations, blood pressure, lipid levels, obesity and metabolic syndrome with cardiovascular disease in black compared to white african patients with ra were recently identified by us [27–29], ethnicity did not impact the il-6-endothelial activation relationship in the present investigation. |
| PubMedID- 25633268 | Aims: matrix metalloproteinases (mmps) and their tissue inhibitors (timps) are dysregulated in metabolic syndrome (mets) and associated with atherosclerosis and cardiovascular disease (cvd). |
| PubMedID- 24676221 | Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn). |
| PubMedID- 24705461 | Aids-related lymphoma (arl), metabolic syndromes (including cardiovascular diseases, cvds; atherosclerosis and other lipid disorders), and hiv-associated dementia (had) – can be considered as all macrophage-mediated disorders in which nef is an unquestioned key factor [10]. |
| PubMedID- 24708775 | In clinical trials, bezafibrate has been highly effective at reducing cardiovascular disease risk in patients with metabolic syndrome or atherogenic dyslipidemia [32,37]. |
| PubMedID- 20300596 | Depression is an independent risk factor for cardiovascular diseases and is associated with metabolic syndrome (mets). |
| PubMedID- 23100048 | In addition to the classic cardiovascular and microvascular diseases, a group of conditions termed geriatric syndromes, described below, also occur at higher frequency in older adults with diabetes and may affect self-care abilities and health outcomes including quality of life (58). |
| PubMedID- 23961478 | For high-risk patients, ldl-c treatment goal was ldl <100 mg/dl but an ldl-c goal of <70 mg/dl was considered a therapeutic option for very high risk patients who had recent heart attacks, cardiovascular disease with diabetes, metabolic syndrome, or severe/poorly controlled risk factors. |
| PubMedID- 24926685 | Nafld is a risk factor for cardiovascular diseases and is associated with metabolic syndrome. |
| PubMedID- 20671994 | On the other hand, no clinical trial evidence indicates that these drugs will reduce risk for cardiovascular disease events in patients with the metabolic syndrome. |
| PubMedID- 25916279 | Conclusions: fetuin-a has a diagnostic potential as a biomarker for liver dysfunction, cardiovascular diseases and disorders associated with metabolic syndrome. |
| PubMedID- 21841320 | Objective: the aim of this study was to evaluate the effects of health checkup and the health education "hokenshido" program based on the concept that visceral fat accumulation causes metabolic syndrome (mets), leading to cardiovascular disease (cvd). |
| PubMedID- 23285034 | It is, however, inconsistent with several other observational studies [4]; [41]; [42], including a recent study by thomas et al who found an optimal vitamin d level to lower all-cause and cardiovascular disease mortality in patients with the metabolic syndrome [43]. |
| PubMedID- 26089614 | Abdominal obesity (ao) and metabolic syndrome (mets) are associated with the cardiovascular disease and type 2 diabetes. |
| PubMedID- 23781121 | These new observations suggest that agonists for par-β/-δ may be effective agents to reverse cholesterol deposition in foam cells in atherotic lesions and therefore decrease cardiovascular disease associated with the metabolic syndrome. |
| PubMedID- 20609696 | In addition, hypertension is an important contributor to increasing cardiovascular disease risk in patients with the cardiometabolic syndrome. |
| PubMedID- 24856006 | Objectives since oils and fats can induce metabolic syndrome, leading to cardiovascular and cerebrovascular diseases, the present study was performed to find out whether the plant oils affect the cerebral hemorrhage in stroke-prone spontaneously hypertensive (shr-sp) rats. |
| PubMedID- 23524050 | The development of gestational diabetes and even milder forms of dysglycemia during pregnancy represents a maternal phenotype at increased subsequent risk for developing type 2 diabetes mellitus, metabolic syndrome, and, with time, overt cardiovascular disease. |
| PubMedID- 22417140 | Recent research has begun to elucidate the effects of hypothalamic inflammation in causing diverse components of metabolic syndrome leading to diabetes and cardiovascular disease. |
| PubMedID- 22321049 | Metabolic disorders such as arterial hypertension (ah), hypercholesterolemia, diabetes mellitus (dm), high triglycerides (tg), abdominal obesity, and metabolic syndrome (mets) are associated with cardiovascular disease (cvd) and cvd-related mortality. |
| PubMedID- 22760893 | Os is associated with endothelial dysfunction and metabolic syndrome, which leads to cardiovascular diseases. |
| PubMedID- 19720470 | Insulin resistance (ir), which is a major component of metabolic syndrome (mets), is associated with cardiovascular disease risk. |
| PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
| PubMedID- 24393433 | Objective: metabolic syndrome (mets) is associated with cardiovascular disease (cvd). |
| PubMedID- 25918936 | The molecular processes that occur in metabolic syndrome can lead to cardiovascular disease pathogenesis and involve risk factors such as oxidative stress and inflammation [2,5]. |
| PubMedID- 21654497 | In the univariate analysis, variables significantly associated with hypertension were age, waist circumference, established cardiovascular disease, family history of hypertension, lipoatrophy, metabolic syndrome, duration of infection, cd4 nadir, hiv rna <50 copies/ml, and antiretroviral treatment. |
Page: 1 2